| Martha Michelle Barlow, DO | |
|
100 S Bliss Ave, Tahlequah, OK 74464-2512 | |
| (918) 458-3100 | |
| (918) 458-3610 |
| Full Name | Martha Michelle Barlow |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 30 Years |
| Location | 100 S Bliss Ave, Tahlequah, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780797456 | NPI | - | NPPES |
| CG9653 | Other | OK | GROUP RAILROAD MEDICARE |
| 100699880B | Other | OK | GROUP MEDICAID NUMBER |
| 08175316 | Other | OK | RAILROAD MEDICARE |
| 100137980C | Medicaid | OK | |
| H37015401 | Other | OK | GROUP MEDICARE NUMBER |
| 730777479002 | Other | OK | GROUP BLUECROSSBLUESHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 3248 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cherokee Nation Home Health Services | Tahlequah, OK | Home health agency |
| Cherokee Nation W W Hastings Indian Hospital | Tahlequah, OK | Hospital |
| Northeastern Health System | Tahlequah, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cherokee Nation | 5799698742 | 329 |
News Archive
The world's first 'fantastic voyage' in which a miniature camera will broadcast live images of the inside of the body is set to take place this Sunday.
Over ten years ago, author Ute Lawrence was involved in a horrific 87-car highway pile-up - the worst in Canadian history. In "The Power of Trauma" (published by iUniverse), Lawrence draws on her mind-altering experience to develop a new perspective on life that has actually empowered her.
Ligand Pharmaceuticals Incorporated announced that data from preclinical studies on its granulocyte colony stimulating factor (G-CSF) receptor agonist program were featured in a poster presentation today at the 55th Annual Meeting of the American Society of Hematology in New Orleans.
The American Society for Gastrointestinal Endoscopy (ASGE) and the American Society for Metabolic & Bariatric Surgery (ASMBS) have issued a new white paper on the potential role of endoscopic bariatric therapies (EBTs) in treating obesity and obesity-related diseases like Type 2 diabetes.
Pharnext SAS, a biopharmaceutical company specializing in the development of innovative treatments for severe neurological diseases and other major unmet medical needs, today announced that the French Agency for Healthcare Product Safety (AFSSAPS) has authorized a Phase II clinical trial with the first drug (a Pleodrug™) generated by the company's Pleotherapy™ technology platform in patients suffering from Charcot-Marie Tooth disease type 1A (CMT1A.
› Verified 8 days ago
| Entity Name | Cherokee Nation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780692723 PECOS PAC ID: 5799698742 Enrollment ID: O20031106000628 |
News Archive
The world's first 'fantastic voyage' in which a miniature camera will broadcast live images of the inside of the body is set to take place this Sunday.
Over ten years ago, author Ute Lawrence was involved in a horrific 87-car highway pile-up - the worst in Canadian history. In "The Power of Trauma" (published by iUniverse), Lawrence draws on her mind-altering experience to develop a new perspective on life that has actually empowered her.
Ligand Pharmaceuticals Incorporated announced that data from preclinical studies on its granulocyte colony stimulating factor (G-CSF) receptor agonist program were featured in a poster presentation today at the 55th Annual Meeting of the American Society of Hematology in New Orleans.
The American Society for Gastrointestinal Endoscopy (ASGE) and the American Society for Metabolic & Bariatric Surgery (ASMBS) have issued a new white paper on the potential role of endoscopic bariatric therapies (EBTs) in treating obesity and obesity-related diseases like Type 2 diabetes.
Pharnext SAS, a biopharmaceutical company specializing in the development of innovative treatments for severe neurological diseases and other major unmet medical needs, today announced that the French Agency for Healthcare Product Safety (AFSSAPS) has authorized a Phase II clinical trial with the first drug (a Pleodrug™) generated by the company's Pleotherapy™ technology platform in patients suffering from Charcot-Marie Tooth disease type 1A (CMT1A.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Martha Michelle Barlow, DO 100 S Bliss Ave, Tahlequah, OK 74464-2512 Ph: (918) 458-3100 | Martha Michelle Barlow, DO 100 S Bliss Ave, Tahlequah, OK 74464-2512 Ph: (918) 458-3100 |
News Archive
The world's first 'fantastic voyage' in which a miniature camera will broadcast live images of the inside of the body is set to take place this Sunday.
Over ten years ago, author Ute Lawrence was involved in a horrific 87-car highway pile-up - the worst in Canadian history. In "The Power of Trauma" (published by iUniverse), Lawrence draws on her mind-altering experience to develop a new perspective on life that has actually empowered her.
Ligand Pharmaceuticals Incorporated announced that data from preclinical studies on its granulocyte colony stimulating factor (G-CSF) receptor agonist program were featured in a poster presentation today at the 55th Annual Meeting of the American Society of Hematology in New Orleans.
The American Society for Gastrointestinal Endoscopy (ASGE) and the American Society for Metabolic & Bariatric Surgery (ASMBS) have issued a new white paper on the potential role of endoscopic bariatric therapies (EBTs) in treating obesity and obesity-related diseases like Type 2 diabetes.
Pharnext SAS, a biopharmaceutical company specializing in the development of innovative treatments for severe neurological diseases and other major unmet medical needs, today announced that the French Agency for Healthcare Product Safety (AFSSAPS) has authorized a Phase II clinical trial with the first drug (a Pleodrug™) generated by the company's Pleotherapy™ technology platform in patients suffering from Charcot-Marie Tooth disease type 1A (CMT1A.
› Verified 8 days ago
Sylvia Soto, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 100 S Bliss Ave, Tahlequah, OK 74464 Phone: 918-458-3100 Fax: 918-458-3115 | |
Shawn Scarberry Miller, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 19600 E Ross St, Tahlequah, OK 74464 Phone: 539-234-4100 Fax: 539-234-4101 | |
Dr. Sharon C Smallwood, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 100 S Bliss Ave, Tahlequah, OK 74464 Phone: 918-458-3100 Fax: 918-458-3610 | |
David Ryan Markes, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 S Bliss Ave, Tahlequah, OK 74464 Phone: 918-458-3100 | |
Rebecca C Lewis, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 17611 South Muskogee Ave, Tahlequah, OK 74464 Phone: 918-207-4911 Fax: 918-458-6221 | |
Dr. Owen Buck Gilmore, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 S Bliss Ave, Tahlequah, OK 74464 Phone: 918-458-3100 | |
Christopher Michael Sacilowski, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 S Bliss Ave, Tahlequah, OK 74464 Phone: 918-458-3100 |